LG Energy Solution Lansing — Production Confirmed, Original Promise Replaced, Available Supply Undisclosed

Status Header

LG Energy Solution Lansing — Delta Township, MI

• Ownership: Originally the GM–LGES joint venture (Ultium Cells); now wholly owned by LGES
• Announced 2022: 50 GWh, NMC, automotive
• Current: 35+ GWh, LFP and NMC, ESS and EV
• Stated status: "Start of Production", 2026-08-18
• Assessed status: Producing. Output rate, yield, customer-qualified volume, LFP/NMC allocation, uncommitted supply and facility-level 45X claims are undisclosed.

LGES says production started, and Argus confirmed it independently. The announcement does not establish that cells have been accepted by a customer at rate, shipped commercially, or made available to an unaffiliated buyer. Automotive qualification treats cells produced and supplier verified at rate as separate gates requiring separate evidence; a plant can sit between them for months, and the public record almost never distinguishes the two.

The Ledger

2022-01-25 — Original commitment

Stated: GM and LGES announced a $2.6 billion Ultium Cells plant. 50 GWh nameplate, 1,700+ jobs, cell production beginning late 2024. Chemistry NMC, application GM EV platforms.

Observed: Michigan's incentive package included a $120 million Critical Industry Program (CIP) grant requiring 1,360 qualified jobs by 2030-12-31, a Renaissance Zone designation requiring $1.5 billion invested by 2027-12-31, and $66.1 million in infrastructure grants. State commitments were sized to the announced scale.

Gap: None at announcement.

2022-05 to 2023-02 — Construction tracks schedule

Stated: No separate groundbreaking announcement identified.

Observed: DOE records and Michigan's construction register date site work from May 2022. Final structural beam installed 2023-02-24. The plant director described late-2024 operations and 1,700 jobs.

Gap: None. Physical construction matched the announced schedule.

2022-11 — DOE filing draws a distinction the company had not

Stated: GM's public headline remained "late 2024" for production start.

Observed: DOE's supplemental environmental assessment projected equipment installation from summer 2023, trial operations from H2 2023, partial operations during 2024 and full production in 2025.

Gap: The DOE filing separated partial operations from full production. The company's "late 2024" did not. Interpretive rather than factual: one headline date covering two different commitments.

2024-01 — Tooling confirmed, workforce signals a slower ramp

Stated: Ultium's hiring event described an initial workforce of 80–100, with production personnel hired "near the end of 2024," the facility operational by end of 2024 and at full production late 2025.

Observed: Michigan's construction register dates process-tooling installation from 2024-01-01. No Lansing-specific equipment order was identified in public materials from Wuxi Lead, Manz or Schuler.

Gap: Tooling confirmed by state records; equipment suppliers not publicly identified. Eighty to one hundred people against a 1,700 target is 5–6% staffing, consistent with a ramp considerably slower than the headline schedule implied.

2024-07 — Company denial, later contradicted by a parent filing

Stated: An Ultium spokesperson said construction remained underway, the building should be substantially complete by October 2024, and equipment would be installed "according to customer demand."

Observed: Trade reporting cited unnamed sources saying two of five planned lines had been installed and the remaining equipment schedule was on hold. An LG Chem Korean regulatory filing published in June 2025 confirmed construction was "temporarily suspended" in July 2024 due to slowing EV demand.

Gap: The spokesperson's denial was contradicted by the parent company's own later regulatory filing. The two-of-five line count rests on unnamed-source reporting and remains unconfirmed. Editorial inference: "according to customer demand" is the earliest public company language suggesting the schedule was no longer set by GM's offtake.

2024-12-02 — GM exits

Stated: GM announced a non-binding agreement to sell its interest to LGES, expected to close in Q1 2025, with GM expecting to recoup its investment. The plant had "nearly 100 employees."

Observed: The transaction was a facility-level asset sale. No pre-sale company disclosure was identified reassigning Lansing to a non-GM customer, to ESS, or to LFP chemistry.

Gap: The chemistry, application and customer pivot was not publicly disclosed before the ownership change. Whether the pivot preceded or followed GM's exit decision is not established in the public record. Workforce at announcement: approximately 100, or 6% of the 1,700 target, 34 months after the original commitment.

2025-03 to 2025-05 — Incentive transfer and sale closing

Stated: MEDC staff told the Michigan Strategic Fund board the amendment did not revise timing, job commitments or minimum-investment requirements. LGES confirmed the acquisition on 2025-05-07, describing the facility as "more than 98% complete."

Observed: The board unanimously approved the transfer, removing the cross-project job credit that had let Lansing headcount count alongside GM's Orion facility. LGES's financial statements record a $2.154 billion asset transfer. Closing occurred after GM's stated Q1 window. Michigan's FY2025 annual report still lists Ultium Cells as the CIP grantee and records zero CIP amendments during FY2025.

Gap: Sale closed, confirmed by financial statements. The transfer was board-approved, but the signed amended CIP agreement is not publicly available, and the annual report's continued listing of Ultium as grantee leaves an administrative discrepancy unresolved. LGES must now meet the 1,360-job commitment at Lansing alone.

2025-09-30 to 2025-11-18 — State records establish a baseline

Stated: No company disclosure identified in this period.

Observed: Michigan's FY2025 annual report recorded 408 non-temporary jobs, company self-reported and not MEDC-verified, and $611.4 million in CIP-qualified investment as of 2025-09-30. The property-tax certificate amended in November 2025 recorded $1.16 billion.

Gap: Three investment figures measuring three different things — $611M CIP-qualified, $1.16B assessed property, $2B+ company claim — against a $1.5B Renaissance Zone minimum due 2027-12-31. Different measurement bases, so not necessarily contradictory. The highest independently recorded figure was 77% of the Renaissance Zone threshold with 25 months remaining.

2026-08-18 — Production start declared

Stated: LGES announced production start: LFP pouch and prismatic cells for ESS through LGES Vertech, with future DTE Energy use, and NMC cells for Toyota EV platforms including the 2027 Highlander. 35+ GWh capacity, approximately 900 employees against a 1,700 target at full scale, more than $2 billion invested.

Observed: Argus confirmed production start. LGES's Q2 2026 earnings reported KRW 241 billion in North America production incentive effect, unallocated by facility. Indeed showed 26 Lansing-area openings on 2026-09-04, spanning operators through engineering, with most manufacturing listings over 30 days old. No WARN notice was identified for the facility from 2024 through the cut-off; Michigan's database requires FOIA for notices not listed.

Gap: Production start confirmed. The announcement names Toyota, LGES Vertech and DTE Energy as channels without disclosing volume commitments or allocation among them. Output rate, yield, operational line count, LFP versus NMC split, customer-accepted shipments, uncommitted volume and facility-level 45X claims are undisclosed, and LGES's financial statements contain no Lansing-specific operating metric. The 35+ GWh figure is 70% of the original 50 GWh, with the "+" leaving the upper bound undefined.

Trajectory Assessment

Everything committed in January 2022 except the building itself was replaced before production was declared: customer, chemistry, application, nameplate and ownership. The schedule slipped roughly 22 months against GM's headline date, more against the DOE filing's partial-operations target, less against its full-production target — which is itself a finding, since the headline date and the regulatory filing were never the same commitment.

For a buyer who modeled Lansing as domestic EV cell supply, that sequence is functionally a cancellation followed by a new announcement at the same address. It matches the joint-venture pattern described in the earlier promise audit: the OEM partner's program weakens, the JV dissolves, the remaining partner redirects the asset, and no tracker records a cancellation because the site is still standing.

On whether the plant exists and is running, the gap between stated and observed has closed. On whether Lansing represents buyer-accessible supply, it has not. No producing US cell maker has publicly quantified uncommitted GWh for unaffiliated buyers, as documented in the addressable-supply inventory, and the production announcement does not change that. The absence of WARN filings and continued job postings are consistent with a ramp, though listings mostly over 30 days old leave the hiring pace ambiguous. Customer acceptance, yield verification, allocation disclosure and a facility-level 45X claim remain unaddressed; the Q2 incentive figure is group-level.

Two state deadlines remain. The CIP grant requires 1,360 qualified jobs by 2030-12-31 against approximately 900 reported, up from 408 a year earlier. The Renaissance Zone requires $1.5 billion invested by 2027-12-31; LGES claims more than $2 billion, the highest independently recorded figure is $1.16 billion. If the company's number reaches state records, both thresholds look reachable. If the state-recorded figure is the operative measure, the investment threshold is worth watching over the next fifteen months.

Last verified: 2026-09-04